-
Mashup Score: 0
Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC - 14 hour(s) ago
Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
The phase 3 LAURA trial highlights the continued overall survival benefit of Tagrisso in pts w/ unresectable S3 EGFR-mutated #NSCLC following chemoradiotherapy. #CancerResearch #LungCancer 🎥🔗 Tune in to hear more from @RamalingamMD, of @WinshipAtEmory: https://t.co/ZAPnfHXIZG https://t.co/QnhSTqRfTu
-
-
Mashup Score: 1True Grit: The Spirit of an Extraordinary Healer - 15 hour(s) ago
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
True Grit: The Spirit of an Extraordinary Healer #Oncology https://t.co/PZLOMCuOso
-
-
Mashup Score: 2Uniting Pediatric and Adult Oncologists to Advance AYA Lymphoma Care - 16 hour(s) ago
Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Uniting Pediatric and Adult Oncologists to Advance AYA #Lymphoma Care @DrAEvens @RutgersCancer @RutgersHealth @RWJBarnabas https://t.co/Csj9EOffHp
-
-
Mashup Score: 0Making Something Positive out of Breast Cancer - 17 hour(s) ago
After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery shirts and pillows.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Making Something Positive out of #BreastCancer https://t.co/BUuBuQbTGf
-
-
Mashup Score: 2
I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
#OvarianCancer Treatment Side Effects Make for a Difficult Balancing Act https://t.co/1GnAQnLtjs
-
-
Mashup Score: 0GLP-1 Drugs Linked to Fewer Obesity-Related Cancers - 21 hour(s) ago
GLP-1 drugs lowered rates of obesity-related cancers and death versus DPP-4s, with no increased cancer risk, study finds.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
GLP-1 Drugs Linked to Fewer Obesity-Related Cancers @ASCO #ASCO25 https://t.co/RVCloGhqkx
-
-
Mashup Score: 3Providing Care and Listening With Compassion During Cancer - 2 day(s) ago
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Meet the heart behind the help.Erin Mensching, RN, OCN, leads the MMRF Patient Navigation Center with compassion, expertise & steadfast dedication to the #MyelomaCommunity—supporting patients from diagnosis through decisions. @theMMRF #CancerSurvivors 🔗 https://t.co/IpbAx5BLxd
-
-
Mashup Score: 1Tips for Combating Lymphedema After Breast Cancer - 2 day(s) ago
With proper precautions, international travel and safeguarding an arm with lymphedema are possible. Always prioritize your health and seek medical advice.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
With proper precautions, international travel and safeguarding an arm with #lymphedema are possible. Always prioritize your health and seek medical advice. https://t.co/7HystLLatH https://t.co/SXcQYGMrxV
-
-
Mashup Score: 3
Among patients with ES-SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Zepzelca Plus Tecentriq Boosts Survival in First-Line ES-SCLC Care @LuisPaz_Ares @unicomplutense @ASCO #ASCO25 #Oncology #LungCancer #LungCancerCare #CancerSurvivor Read more here: https://t.co/ubAeZXjk8W https://t.co/koQi09whdZ
-
Leronlimab increased PD-L1 in patients with triple-negative #BreastCancer, potentially making cold tumors responsive to immune checkpoint inhibitors. @CytoDyn https://t.co/YuG1f5hZHL